Skip to content

Efficacy and Safety of Acne Lotion in the Treatment of Facial Acne Vulgaris

Double Blind, Randomized, Placebo Controlled Trial for Evaluation of Efficacy and Safety of Acne Lotion in the Treatment of Facial Acne Vulgaris

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/05/001758
Enrollment
50
Registered
2011-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Facial Acne Vulgaris

Interventions

Intervention1: Acne Lotion: Sulphacetamide sodium plus Nicotinamide plus Boric acid Lotion To be applied few drops on your palm with the help of index finger and with other hand apply the lotion on a

Sponsors

Mayer Organics Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Mild to moderate acne irrespective of sex and social status -Subjects who have given written informed consent & ascent (where applicable)

Exclusion criteria

Exclusion criteria: -Participation in another study during the past 30 days -Cigarette smokers -Alcoholics & drug abusers -Pregnant or lactating female -Females taking contraceptive pills or hormonal preparation -Use of anti-acne therapy in last 30 days -Patients having any systemic illness or using any systemic therapy -Patient with hypersensitivity to sulfur containing drugs -Poor compliance with study protocol

Design outcomes

Primary

MeasureTime frame
-Reduction in acne number and severity (comedones,Pustules, Nodules) Treatment -Change from the baseline in the inflammatory lesion count -Change from the baseline in the non-inflammatory lesion count Timepoint: 15 Days, 30 Days, 45 Days

Secondary

MeasureTime frame
Safety and tolerabilityTimepoint: 15 Days, 30 Days and 45 Days

Countries

India

Contacts

Public ContactDr Himanshu Tayade

Meyer Organics pvt ltd

himanshu.tayade@gmail.com02225817140

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026